Thomas Zoller
Expertise in
3
conditions

Thomas Zoller

Ansbacher Str. 17-19, 
Berlin, BE, DE 
Expertise in
3
conditions
Ansbacher Str. 17-19, 
Berlin, BE, DE 

Overview

Thomas Zoller practices practicing medicine in Berlin, Germany.

Mr. Zoller is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Long Haul COVID, COVID-19, Severe Acute Respiratory Syndrome (SARS), and Hemolysis.

He is actively involved in clinical research, co-authoring 75 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Ansbacher Str. 17-19, Berlin, BE 10787, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Treatment Optimization of Newly Diagnosed Ph/BCR-ABL Positive Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase With Nilotinib vs. Nilotinib Plus Interferon Alpha Induction and Nilotinib or Interferon Alpha Maintenance Therapy
Treatment Optimization of Newly Diagnosed Ph/BCR-ABL Positive Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase With Nilotinib vs. Nilotinib Plus Interferon Alpha Induction and Nilotinib or Interferon Alpha Maintenance Therapy
Enrollment Status: Completed
Publish Date: May 10, 2023
Intervention Type: Drug
Study Drugs: Peginterferon ?2b, Nilotinib
Study Phase: Phase 3
Proof of Concept Study of Eurartesim® in Patients With Imported Uncomplicated Plasmodium Vivax Malaria
Proof of Concept Study of Eurartesim® in Patients With Imported Uncomplicated Plasmodium Vivax Malaria
Enrollment Status: Terminated
Publish Date: September 17, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

75 Total Publications

Correction: Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP).
Correction: Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP).
Journal: Infection
Published: July 27, 2026

Frequently Asked Questions about Thomas Zoller

Is Thomas Zoller a top-rated expert for Long Haul COVID?

MediFind is an objective health platform that identifies experts based on real-world data. Thomas Zoller is classified as an Distinguished expert for Long Haul COVID, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Thomas Zoller participate in research or clinical trials?

Yes. Thomas Zoller has published 75 articles and abstracts on conditions like Long Haul COVID. You can view a list of Thomas Zoller's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Zoller's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile